5JYQ image
Deposition Date 2016-05-15
Release Date 2016-09-07
Last Version Date 2023-11-15
Entry Detail
PDB ID:
5JYQ
Keywords:
Title:
Structure of Conus Geographus insulin G1
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
1.95 Å
R-Value Free:
0.23
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 4 3 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Insulin 1
Chain IDs:A
Chain Length:20
Number of Molecules:1
Biological Source:Conus geographus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Insulin 1b
Chain IDs:B
Chain Length:23
Number of Molecules:1
Biological Source:Conus geographus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CGU A GLU modified residue
CY3 A CYS modified residue
HYP B PRO modified residue
Ligand Molecules
Primary Citation
A minimized human insulin-receptor-binding motif revealed in a Conus geographus venom insulin.
Nat.Struct.Mol.Biol. 23 916 920 (2016)
PMID: 27617429 DOI: 10.1038/nsmb.3292

Abstact

Insulins in the venom of certain fish-hunting cone snails facilitate prey capture by rapidly inducing hypoglycemic shock. One such insulin, Conus geographus G1 (Con-Ins G1), is the smallest known insulin found in nature and lacks the C-terminal segment of the B chain that, in human insulin, mediates engagement of the insulin receptor and assembly of the hormone's hexameric storage form. Removal of this segment (residues B23-B30) in human insulin results in substantial loss of receptor affinity. Here, we found that Con-Ins G1 is monomeric, strongly binds the human insulin receptor and activates receptor signaling. Con-Ins G1 thus is a naturally occurring B-chain-minimized mimetic of human insulin. Our crystal structure of Con-Ins G1 reveals a tertiary structure highly similar to that of human insulin and indicates how Con-Ins G1's lack of an equivalent to the key receptor-engaging residue PheB24 is mitigated. These findings may facilitate efforts to design ultrarapid-acting therapeutic insulins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures